SEARCH

SEARCH BY CITATION

References

  • 1
    Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000; 21(2):11537.
  • 2
    Judex S, Gupta S, Rubin C. Regulation of mechanical signals in bone. Orthod Craniofac Res. 2009; 12(2):94104.
  • 3
    Jaul E, Malcov T, Menczel J. Osteoporosis in tube-fed bed-ridden elderly female patients. J Am Geriatr Soc. 2009; 57(7):131820.
  • 4
    Tavella S, Ruggiu A, Giuliani A, Brun F, Canciani B, Manescu A, Marozzi K, Cilli M, Costa D, Liu Y, Piccardi F, Tasso R, Tromba G, Rustichelli F, Cancedda R. Bone turnover in wild type and pleiotrophin-transgenic mice housed for three months in the International Space Station (ISS). PLos One. 2012; 7(3):e33179.
  • 5
    Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol. 2011; 12(8):71523.
  • 6
    Hayden MS, Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012; 26(3):20334.
  • 7
    Iotsova V, Caamaño J, Loy J, Yang Y, Lewin A, Bravo R. Osteopetrosis in mice lacking NF-κB1 and NF-kappaB2. Nat Med. 1997; 3(11):12859.
  • 8
    Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 1997; 11(24):348296.
  • 9
    Jimi E, Aoki K, Saito H, D'Acquisto F, May MJ, Nakamura I, Sudo T, Kojima T, Okamoto F, Fukushima H, Okabe K, Ohya K, Ghosh S. Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med. 2004; 10(6):61724.
  • 10
    Abu-Amer Y, Darwech I, Otero J. Role of the NF-κB axis in immune modulation of osteoclasts and bone loss. Autoimmunity. 2008; 41(3):20411.
  • 11
    Chang J, Wang Z, Tang E, Fan Z, McCauley L, Franceschi R, Guan K, Krebsbach PH, Wang CY. Inhibition of osteoblastic bone formation by nuclear factor-κB. Nat Med. 2009; 15(6):6829.
  • 12
    Yamazaki M, Fukushima H, Shin M, Katagiri T, Doi T, Takahashi T, Jimi E. TNFα represses BMP signaling by interfering with the DNA binding of Smads through the activation of NF-κB. J Biol Chem. 2004; 284(51):3598795.
  • 13
    Alles N, Soysa NS, Hayashi J, Khan M, Shimoda A, Shimokawa H, Ritzeler O, Akiyoshi K, Aoki K, Ohya K. Suppression of NF-κB increases bone formation and ameliorates osteopenia in ovariectomized mice. Endocrinology. 2010; 151(10):462634.
  • 14
    Granet C, Boutahar N, Vico L, Alexandre C, Lafage-Proust MH. MAPK and SRC-kinases control EGR-1 and NF-κB inductions by changes in mechanical environment in osteoblasts. Biochem Biophys Res Commun. 2001; 15; 284(3):62231.
  • 15
    Nagel T, Resnick N, Dewey CF Jr, Gimbrone MA Jr. Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler Thromb Vasc Biol. 1999; 19(8):182534.
  • 16
    Chen NX, Geist DJ, Genetos DC, Pavalko FM, Duncan RL. Fluid shear-induced NF-κB translocation in osteoblasts is mediated by intracellular calcium release. Bone. 2003; 33(3):399410.
  • 17
    Hunter RB, Stevenson E, Koncarevic A, Mitchell-Felton H, Essig DA, Kandarian SC. Activation of an alternative NF-κB pathway in skeletal muscle during disuse atrophy. FASEB.J. 2002; 16(6):52938.
  • 18
    Hunter RB, Kandarian SC. Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest. 2004; 114(10):150411.
  • 19
    Tatsumi S, Ishii K, Amizuka N, Li M, Kobayashi T, Kohno K, Ito M, Takeshita S, Ikeda K. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 2007; 5(6):46475.
  • 20
    Wang Y, Liu W, Masuyama R, Fukuyama R, Ito M, Zhang Q, Komori H, Murakami T, Moriishi T, Miyazaki T, Kitazawa R, Yoshida CA, Kawai Y, Izumi S, Komori T. Pyruvate dehydrogenase kinase 4 induces bone loss at unloading by promoting osteoclastogenesis. Bone. 2012; 50(1):40919.
  • 21
    Soysa NS, Alles N, Weih D, Lovas A, Mian AH, Shimokawa H, Yasuda H, Weih F, Jimi E, Ohya K, Aoki K. The pivotal role of the alternative NF-κB pathway in maintenance of basal bone homeostasis and osteoclastogenesis. J Bone Miner Res. 2010; 25(4):80918.
  • 22
    Maruyama T, Fukushima H, Nakao K, Shin M, Yasuda H, Weih F, Doi T, Aoki K, Alles N, Ohya K, Hosokawa R, Jimi E. Processing of the NF-κB2 precursor, p100, to p52 is critical for RANKL-induced osteoclast differentiation. J Bone Miner Res. 2010; 25(5):105867.
  • 23
    Mikuni-Takagaki Y, Suzuki Y, Kawase T, Saito S. Distinct responses of different populations of bone cells to mechanical stress. Endocrinology. 1996; 137(5):202835.
  • 24
    Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol. 1994; 127(6):175566.
  • 25
    Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17(10):12314.
  • 26
    Owen ME, Friednstein AJ. Stromal cells: marrow-derived osteogenic precursors. In: Evered D, Harnett D, editors. Cellular and molecular biology of vertebrate hard tissues. Ciba Foundation Symposium 136, Chichester UK: John Wiley & Sons; p. 4252. 1988.
  • 27
    Mizoguchi T, Muto A, Udagawa N, Arai A, Yamashita T, Hosoya A, Ninomiya T, Nakamura H, Yamamoto Y, Kinugawa S, Nakamura M, Nakamichi Y, Kobayashi Y, Nagasawa S, Oda K, Tanaka H, Tagaya M, Penninger JM, Ito M, Takahashi N. Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. J Cell Biol. 2009; 184(4):54154.
  • 28
    Nakashima T, Hayashi M, Takayanagi H. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab. 2012 Nov; 23(11):58290.
  • 29
    Jimi E, Ghosh S. Role of nuclear factor-κB in the immune system and bone. Immunol Rev. 2005; 208:807.
  • 30
    Hurst JE, Fitts RH. Hindlimb unloading-induced muscle atrophy and loss of function: protective effect of isometric exercise. J Appl Physiol. 2003; 95(4):140517.
  • 31
    Cavanagh PR, Licata AA, Rice AJ. Exercise and pharmacological countermeasures for bone loss during long-duration space flight. Gravit Space Biol Bull. 2005; 18(2):3958.
  • 32
    Kondo H, Ezura Y, Nakamoto T, Hayata T, Notomi T, Sorimachi H, Takeda S, Noda M. MURF1 deficiency suppresses unloading-induced effects on osteoblasts and osteoclasts to lead to bone loss. J Cell Biochem. 2011; 112(12):352530.
  • 33
    Elkasrawy MN, Hamrick MW. Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact. 2010; 10(1):5663.